Clinical Trial Update: An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase I/II trial evaluating the PLENA regimen for unresectable pancreatic cancer or biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Pancreatic Cancer

Drugs mentioned

• PLENA regimen

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Pancreatic Cancer, Biliary Tract Cancer | Phase 1, Phase 2 | Status: UNKNOWN